Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Drachman, Brian
NCT05951049: A Study of AT-02 in Subjects With Systemic Amyloidosis.	Recruiting	2	120	Europe, US, RoW	AT02	Attralus, Inc., Novotech (Australia) Pty Limited	Amyloidosis; Systemic	02/26	02/26
AT02-001, NCT05521022: Study of AT-02 in Healthy Volunteers and Subjects With Systemic Amyloidosis	Recruiting	1	100	US, RoW	AT-02, AT-02 (Placebo)	Attralus, Inc., Novotech (Australia) Pty Limited	Amyloidosis; Systemic	03/25	03/25
EDONA, NCT05311488: Early Detection of Neuropathy in ATTRv	Active, not recruiting	N/A	47	US	neurofilament light chain, In-vivo Meissner Corpuscle imaging, Nerve conduction study	University of Pennsylvania, Ionis Pharmaceuticals, Inc., AstraZeneca	Hereditary Amyloidosis, Transthyretin-Related	06/25	02/29
Divito, Patricia
No trials found